Affinity Asset Advisors, LLC
- SEC CIK
- 0001773195
- Latest filing
- Aug 13, 2026
VRDN holding history
Viridian Therapeutics, Inc. in every 13F filed by Affinity Asset Advisors, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
VRDN overviewAll 13F holders of VRDNFull Q2 2026 holdings
- Shares (Q2 2026)
- 250,000
- Value
- $4.59M
- % of portfolio
- 0.2%
- Quarters held
- 12
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 250,000 | $4.59M | 0.2% | 00.0% | Unchanged | Holders |
| Q1 2026 | 250,000 | $4.89M | 0.3% | 00.0% | Unchanged | Holders |
| Q4 2025 | 250,000 | $7.78M | 0.6% | 00.0% | Unchanged | Holders |
| Q3 2025 | 250,000 | $5.39M | 0.5% | −140,000−35.9% | Reduced | Holders |
| Q2 2025 | 390,000 | $5.45M | 0.8% | 00.0% | Unchanged | Holders |
| Q1 2025 | 390,000 | $5.26M | 0.8% | +230,386+144.3% | Added | Holders |
| Q4 2024 | 159,614 | $3.06M | 0.5% | −365,386−69.6% | Reduced | Holders |
| Q3 2024 | 525,000 | $11.9M | 1.9% | +375,000+250.0% | Added | Holders |
| Q2 2024 | 150,000 | $1.95M | 0.3% | +150,000 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −50,000−100.0% | Sold out | Holders |
| Q4 2023 | 50,000 | $1.09M | 0.2% | +50,000 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −20,660−100.0% | Sold out | Holders |
| Q2 2022 | 20,660 | $239.0K | 0.1% | −29,340−58.7% | Reduced | Holders |
| Q1 2022 | 50,000 | $925.0K | 0.4% | +50,000 | New | Holders |